Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in GLSI — Greenwich LifeSciences, Inc.

CIK 1390777 NEW YORK, NY
Back to GLSI Full portfolio

Position in GLSI

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$1,123,732
+$6,252 QoQ
Shares Held
47,900
+3.0% QoQ
Ownership
0.326%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 57 holders
Holding Since
Jun 2021
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GLSI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. GLSI ranks #186 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in GLSI

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,123,732 47,900
2026-03-31 $1,117,480 46,523
2025-12-31 $291,323 13,866
2025-09-30 $150,521 15,128
2025-06-30 $132,384 14,596
2025-03-31 $106,876 11,203
2024-12-31 $125,808 11,203
2024-09-30 $160,986 11,203
2024-06-30 $263,991 15,295
2022-03-31 $198,435 10,114
2021-12-31 $246,072 10,114
2021-09-30 $388,081 9,933
2021-06-30 $299,479 6,664